Antineoplastic agents. 465. Structural modification of resveratrol: Sodium resverastatin phosphate

Journal of Medicinal Chemistry

Volumn 45, Issue 12, 2002, Pages 2534-2542

  Pettit, George R ^a   Grealish, Matthew P ^a   Jung, M Katherine ^b   Hamel, Ernest ^b   Pettit, Robin K ^a   Chapuis, J Charles ^a   Schmidt, Jean M ^a  

^a ARIZONA STATE UNIVERSITY   (United States)

^b NATIONAL CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

3,4',5 TRIMETHOXYSTILBENE; ANTINEOPLASTIC AGENT; BENZOPHENONE DERIVATIVE; COMBRETASTATIN A4; PHENSTATIN; RESVERATROL; SODIUM RESVERASTATIN PHOSPHATE; STILBENE DERIVATIVE; UNCLASSIFIED DRUG;

ANGIOGENESIS; ANTIMICROBIAL ACTIVITY; ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER INHIBITION; CHEMICAL MODIFICATION; DRUG ACTIVITY; DRUG SELECTIVITY; DRUG STRUCTURE; DRUG SYNTHESIS; HUMAN; HUMAN CELL; METHYLATION; NONHUMAN; STRUCTURE ACTIVITY RELATION;

ANTI-BACTERIAL AGENTS; ANTI-INFECTIVE AGENTS; ANTINEOPLASTIC AGENTS; BACTERIA; BIOPOLYMERS; CELL DIVISION; DRUG SCREENING ASSAYS, ANTITUMOR; FUNGI; HUMANS; MICROBIAL SENSITIVITY TESTS; PHOSPHORIC ACID ESTERS; PRODRUGS; STEREOISOMERISM; STILBENES; STRUCTURE-ACTIVITY RELATIONSHIP; TUBULIN; TUMOR CELLS, CULTURED;

EID: 0037030688     PISSN: 00222623     EISSN: None     Source Type: Journal    
DOI: 10.1021/jm010119y     Document Type: Article

References (48)

1. Separation of the bryostatin derivatives by high performance liquid chromatography
2. Fluorinated resveratrol and pterostilbene
3. Resveratrol is a selective human cytochrome P450 1A1 inhibitor
4. Isolation, synthesis, and antiplatelet aggregation activity of resveratrol 3-O-β-D-glucopyranoside and related compounds
5. A global survey of trans-resveratrol concentrations in commercial wines
6. Concentration of the phytoalexin resveratrol in wine
7. Stilbene derivatives from Cissus quadrangularis
8. Effects of stilbene components of the root of Polygonum cuspidatum Sieb. et Zucc. on lipid metabolism
9. 3,5,4′-Trihydroxystilbene as a phytoalexin from groundnuts (Arachis hypogaea)
10. The production of resveratrol by grape berries in different developmental stages
11. Anti-leukaemic compounds derived from stilbenes in Picea abies bark
12. Phytoalexin production potential of grape berries
13. Identification of pterostilbene as a phytoalexin from Vitis vinifera leaves
14. The relationship of resveratrol production to infection of grapevine leaves by Botrytis cenerea
15. An antiplatelet principle of Veratrum formosanum
16. The ichthyotoxicity and coronary vasodilator action of 3,3′-dihydroxy-α,β-diethylstilbene
17. Inhibition of human LDL oxidation by resveratrol
18. More on antioxidant activity of resveratrol in red wine
19. The red wine phenolics trans-resveratrol and quercetin block human platelet-aggregation and eicosanoid synthesis-implications for protection against coronary heart-disease
20. Resveratrol inhibits intestinal tumorigenesis and modulates host-defense-related gene expression in an animal model of human familial adenomatous polyposis
21. Resveratrol induces colon tumor cell apoptosis independently of p53 and preceded by epithelial differentiation, mitochondrial proliferation and membrane potential collapse
22. Cancer chemopreventive activity of resveratrol, a natural product derived from grapes
23. Antimutagenic effects of resveratrol against TrpP-1
24. Amelioration of oxidative stress by antioxidants and resveratrol in PC12 cells
25. Antiproliferative effect of synthetic resveratrol on human breast epithelial cells
26. Kinase inhibition from Polygonum cuspidatum
27. Resveratrol is a selective human cytochrome P450 1A1 inhibitor
28. Resveratrol, an antioxidant present in red wine, induces apoptosis in human promyelocytic leukemia (HL-60) cells
29. Resveratrol tetramers from Vatica diospyoides
30. Antitumor agents 200. Cytotoxicity of naturally occurring resveratrol oligomers and their acetate derivatives
31. Biotransformation of resveratrol to piceid by Bacillus cereus
32. Isolation and structure of combretastatin
33. Synthesis of natural (-)-combretastatin
34. Isolation and structure of the strong cell growth and tubulin inhibitor combretastatin A-4
35. Antineoplastic agents 291. Isolation and synthesis of combretastatin A-4, A-5, and A-6
36. Anti-vascular approaches to solid tumour therapy: Evaluation of combretastatin A-4 phosphate
37. Antineoplastic agents 389. New syntheses of the combretastatin A-4 prodrug
38. Synthesis and evaluation of analogues of (Z)-1- (4-methoxyphenyl)-2-(3,4,5-trimethoxyphenyl)ethane as potential cytotoxic and antimitotic agents
39. Condensation of dimethyl-α-resorcylyl chlorides with phenol ether
40. Feasibility of a high-flux anticancer screen using a diverse panel of cultured human tumor cell lines
41. Antineoplastic agents 443. Synthesis of the cancer cell growth inhibitor hydroxyphenstatin and its sodium diphosphate prodrug
42. Antineoplastic agents. 379. Synthesis of phenstatin phosphate
43. Antimitotic natural products combretastatin A-4 and combretastatin A-2: Studies on the mechanism of their inhibition of the binding of colchicine to tubulin
44. Structure-activity analysis of the interaction of curacin A, the potent colchicine site antimitotic agent, with tubulin and effects of analogues on the growth of MCF-7 breast cancer cells